World J Mens Health.
2020 Jul;38(3):254-255. 10.5534/wjmh.200089.
Phosphodiesterase Type 5 Inhibitors and COVID-19: Are They Useful In Disease Managment?
- Affiliations
-
- 1Urology Unit, Villa Donatello Hospital, Florence, Italy
- KMID: 2502994
- DOI: http://doi.org/10.5534/wjmh.200089
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Chronic Low Dosing of Phosphodiesterase Type 5 Inhibitor for Erectile Dysfunction
- Dipeptidyl Peptidase-4 Inhibitors and COVID-19-Related Deaths among Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Observational Studies
- Comprehensive Review of COVID-19 on Benign Prostate Hyperplasia Patient Symptoms
- A Case of Glycogen Storage Disease Type V with Rhabdomyolysis after COVID-19 Vaccination
- Treatment Strategy for Non-Responders to PDE5 Inhibitors
